The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
1 pt

Opinion on  Oncolytics Biotech Inc. (ONCY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Neutral on ONCY ...

Aug 27, 2008 03:49 PM GMT
The_end_100_gif
Return Risk
+2.98% MID
Sr. Associate

I expect a new test for 1,60$ will come Y M


ONCY:  This call was made on 08/27/08 @ $1.78
Rating:   Neutral/Hold   $1.78 (08/27/08)
Closed:   11/28/2008 @ $1.12 (-37.08% in 93 days)


Comments (1)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 410 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Oncolytics Biotech Inc. (ONCY)
   SocialPicks Sentiment:    N/A

   This Quarter's Sentiment:
All:
60.0%
Top:
0.0%




Latest Picks by Yannis Maarten
Symbol SP Sentiment Rating Return Since
VRTX Negative +1.56% 05/25/12
HPQ Negative -0.13% 05/24/12
DELL Negative +17.18% 05/22/12
PWER Negative -1.11% 05/22/12
CSIQ Negative -4.48% 05/18/12

View All >
   
Yannis Maarten previously rated ONCY
Negative +10.37% Oncolytics Biotech Inc. (ONCY) $ 1,00 possible - 4/2011 loss per common share -0.41
03/27/2012
9
Negative -32.51% Oncolytics Biotech Inc. down to 2,00 $
11/19/2009
10
Negative -53.58% Oncolytics Biotech Inc. the bottom is 1,00 $ good for a new test
11/28/2008
1





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch